» Articles » PMID: 15784588

Genetic Diversity and Carriage Dynamics of Neisseria Lactamica in Infants

Overview
Journal Infect Immun
Date 2005 Mar 24
PMID 15784588
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Neisseria lactamica, a harmless human commensal found predominantly in the upper respiratory tracts of infants, is closely related to Neisseria meningitidis, a pathogen of global significance. Colonization with N. lactamica may be responsible for the increase in immunity to meningococcal disease that occurs during childhood, when rates of meningococcal carriage are low. This observation has led to the suggestion that N. lactamica whole cells or components are potential constituents of novel meningococcal vaccines. However, the dynamics of carriage and population diversity of N. lactamica in children are poorly understood, presenting difficulties for the choice of representative isolates for use in vaccine development. This problem was addressed by the multilocus sequence typing of N. lactamica isolates from two longitudinal studies of bacterial carriage in infants. The studies comprised 100 and 216 subjects, with N. lactamica carriage monitored from age 4 weeks until age 96 weeks and from age 2 weeks until age 24 weeks, respectively. The maximum observed carriage rate was 44% at 56 weeks of age, with isolates obtained on multiple visits for the majority (54 of 75, 72%) of carriers. The N. lactamica isolates were genetically diverse, with 69 distinct genotypes recovered from the 75 infants. Carriage was generally long-lived, with an average rate of loss of under 1% per week during the 28 weeks following acquisition. Only 11 of the 75 infants carried more than one genotypically unique isolate during the course of the study. Some participants shared identical isolates with siblings, but none shared identical isolates with their parents. These findings have implications for the design of vaccines based on this organism.

Citing Articles

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.

Viviani V, Fantoni A, Tomei S, Marchi S, Luzzi E, Bodini M NPJ Vaccines. 2023; 8(1):54.

PMID: 37045859 PMC: 10097807. DOI: 10.1038/s41541-023-00651-9.


Colonization Rate and Associated Factors of Non-Pathogenic Species, and Among Healthy School Children in Gondar, Northwest Ethiopia.

Belachew T, Assefa M, Tefera Z, Fenta A, Biset S Infect Drug Resist. 2023; 16:369-378.

PMID: 36714354 PMC: 9879043. DOI: 10.2147/IDR.S395343.


Controlled human infection with in late pregnancy to measure horizontal transmission and microbiome changes in mother-neonate pairs: a single-arm interventional pilot study protocol.

Theodosiou A, Laver J, Dale A, Cleary D, Jones C, Read R BMJ Open. 2022; 12(5):e056081.

PMID: 35584870 PMC: 9119180. DOI: 10.1136/bmjopen-2021-056081.


Meningococcal Quinolone Resistance Originated from Several Commensal Species.

Chen M, Zhang C, Zhang X, Chen M Antimicrob Agents Chemother. 2019; 64(2).

PMID: 31740556 PMC: 6985708. DOI: 10.1128/AAC.01494-19.


Genomic characterization of novel Neisseria species.

Diallo K, Maclennan J, Harrison O, Msefula C, Sow S, Daugla D Sci Rep. 2019; 9(1):13742.

PMID: 31551478 PMC: 6760525. DOI: 10.1038/s41598-019-50203-2.


References
1.
Alber D, Oberkotter M, Suerbaum S, Claus H, Frosch M, Vogel U . Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers. J Clin Microbiol. 2001; 39(5):1710-5. PMC: 88014. DOI: 10.1128/JCM.39.5.1710-1715.2001. View

2.
Suker J, Feavers I, Maiden M . Structural analysis of the variation in the major outer membrane proteins of Neisseria meningitidis and related species. Biochem Soc Trans. 1993; 21(2):304-6. DOI: 10.1042/bst0210304. View

3.
Kumar S, Tamura K, Jakobsen I, Nei M . MEGA2: molecular evolutionary genetics analysis software. Bioinformatics. 2001; 17(12):1244-5. DOI: 10.1093/bioinformatics/17.12.1244. View

4.
Stackebrandt E, Frederiksen W, Garrity G, Grimont P, Kampfer P, Maiden M . Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int J Syst Evol Microbiol. 2002; 52(Pt 3):1043-1047. DOI: 10.1099/00207713-52-3-1043. View

5.
Oliver K, Reddin K, Bracegirdle P, Hudson M, Borrow R, Feavers I . Neisseria lactamica protects against experimental meningococcal infection. Infect Immun. 2002; 70(7):3621-6. PMC: 128090. DOI: 10.1128/IAI.70.7.3621-3626.2002. View